Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010]

NCT02486718 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

1280

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG: Atezolizumab
DRUG: Cisplatin
DRUG: Vinorelbine
DRUG: Docetaxel
DRUG: Gemcitabine
DRUG: Pemetrexed

Sponsor

Hoffmann-La Roche